ARTELO BIOSCIENCES, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA, 92075
Mailing Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA, 92075
Phone
858-925-7049
Fiscal Year End
1231
EIN
331220924
Financial Overview
FY2025
$600K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | April 3, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| S-1/A IPO registration amendment | March 24, 2026 | View on SEC |
| S-1 IPO registration statement | March 24, 2026 | View on SEC |
| S-1/A IPO registration amendment | March 23, 2026 | View on SEC |
| S-1 IPO registration statement | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
Material Events
8-K
Strategy Change
March 17, 2026
High Impact
- Aims to meet NASDAQ listing requirements and avoid delisting.
- Intends to improve market perception and attract a broader range of investors, including institutional funds.
8-K
Strategy Change
March 6, 2026
High Impact
- Aims to improve stock's market standing and liquidity.
- Seeks to regain and maintain compliance with Nasdaq's $1.00 minimum bid price requirement.
8-K
Financial Distress
February 5, 2026
High Impact
- ARTELO secured a vital Nasdaq listing extension, preventing immediate delisting and preserving trading accessibility.
- The company has until March 30, 2026, to regain compliance with Nasdaq's financial standards, providing a defined timeframe.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.